Jump to main content
Jump to site search


Anti-vascular nano agents: a promising approach for cancer treatment

Author affiliations

Abstract

Anti-vascular agents (AVAs) are a class of promising therapeutic agents with tumor vasculature targeting properties, which can be divided into two types: anti-angiogenic agents (AAAs, inhibit angiogenesis factors) and vascular disrupting agents (VDAs, disrupt established tumor vasculature). AVAs exhibit an enhanced anti-cancer effect by cutting off the oxygen and nutrition supplement channels of tumors. However, the intrinsic drawbacks, such as poor hydrophilicity, undesirable membrane permeability and inferior tumor targeting ability, discount their anti-vascular efficacy. Fortunately, the development of nanotechnology has brought an opportunity for efficient delivery of AVAs to tumour sites with great therapeutic efficacy. The works summarized in this review will provide an understanding of recent advances of anti-vascular nano agents (AVNAs) with a goal to define the mechanism of anti-vascular-based cancer therapy and discuss the challenges and opportunities of AVNAs for clinical translation.

Graphical abstract: Anti-vascular nano agents: a promising approach for cancer treatment

Back to tab navigation

Article information


Submitted
30 Dec 2019
Accepted
11 Mar 2020
First published
12 Mar 2020

J. Mater. Chem. B, 2020, Advance Article
Article type
Review Article

Anti-vascular nano agents: a promising approach for cancer treatment

D. Chen, X. Qu, J. Shao, W. Wang and X. Dong, J. Mater. Chem. B, 2020, Advance Article , DOI: 10.1039/C9TB02957E

Social activity

Search articles by author

Spotlight

Advertisements